erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
RSL3 - Stanford University
Changyanning tablet alleviates Crohn's disease by inhibiting GPX4-mediated ferroptosis. (PubMed, J Ethnopharmacol) - Jan 28, 2025 - "CYN alleviates CD by inhibiting GPX4-mediated ferroptosis, highlighting its clinical potential for treating CD and enhancing the understanding of the pathogenic and therapeutic mechanisms associated with CD." 
Journal • Crohn's disease • Dyspepsia • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Pain • GPX4 • SLC7A11
http://www.ncbi.nlm.nih.gov/pubmed/39870334
 
Changyong Chen; Chuang Wang; Defa Yu; Haonan Ruan; Jiaoyang Luo; Jing Zhang; Meihua Yang; Qing Ru; Ying Huang; Yunyun Wang
 
Jan 28, 2025
 
Prev Next